Compound ID | 150
Aztreonam + Avibactam
Class: Beta-lactam (monobactam) + beta-lactamase inhibitor (non-beta-lactam beta-lactamase inhibitor, diazabicyclooctane [DBO])
| Spectrum of activity: | Gram-negative |
| Details of activity: | Metallo-β-lactamase-producing gram-negative organisms such as Enterobacteriaceae and Pseudomonas aeruginosa |
| Combined with other compounds: | Yes |
| Institute where first reported: | Pfizer Inc./Allergan PLC (formerly Actavis) |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Phase 3 (NCT03329092) |
| Development status: | Active (as of 2024) |
| Chemical structure(s): |
| External links: | |
| Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5742832 |
| Guide to Pharmacology: | aztreonam |
| Citations: |
|
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.